一般財団法人化学及血清療法研究所が製造販売するインフルエンザHAワクチンについて｜厚生労働省
https://www.mhlw.go.jp/stf/houdou/0000101868.htmlThe evidence pack includes the HTML, screenshot, summary, and metadata in one ZIP file. For signed-in saves, Kiroku also starts the external RFC 3161 timestamp flow automatically. Downloading the evidence pack is available on Pro. If any asset is still missing, Kiroku prepares it before the download starts.
External timestamp
The evidence pack includes the capture manifest and the RFC 3161 request/response files.
一般財団法人化学及血清療法研究所が製造販売するインフルエンザHAワクチンについて｜厚生労働省
Open the dedicated viewer to inspect the saved page with archive metadata pinned above it.
This is a self-contained HTML copy with CSS and images embedded, so it still renders even if the original page disappears.
The dedicated viewer keeps the original URL and saved timestamp visible while you review the archived HTML.
This page announces the Ministry of Health, Labour and Welfare's decision regarding influenza HA vaccine manufactured by the Chemical and Serum Therapy Research Institute. The ministry had requested suspension of shipments in September due to discrepancies between approval documentation and manufacturing practices. Following detailed review, no significant impact on product quality and safety was identified. The Infectious Disease Division of the Health Science Council concluded that shipment should be permitted to prevent influenza transmission and avoid supply shortages. Consequently, the ministry lifted the shipment suspension order on the announced date.
